SSRF in Cbioportal

CVE-2024-41668

The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.

Vulnerability class: SSRF (Server-Side Request Forgery)

Published · last modified .

CVSS v3 metric

CVSS v3 base score 8.3 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L.

EPSS exploit prediction

EPSS: 0.006 (45.9th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 46th percentile — 45.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2024-41668: held from 0.006 to 0.006.

EPSS over last 30 days · oldest: 0.006 · newest: 0.006 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2024-41668?
CVE-2024-41668 is a high-severity vulnerability in Cbioportal, classified under Server-Side Request Forgery (SSRF). CVSS score: 8.3/10. Published 2024-07-23.
How severe is CVE-2024-41668?
High severity. CVSS v3 base score is 8.3 out of 10.